There’s been a revolving door of viral social media posts recently promoting the idea that you’ll boost your chances of conceiving if you take GLP-1 weight-loss medications. Unfortunately, the promise of the “Ozempic baby boom” is more myth than reality. While there is some connection between GLP-1s (semaglutide, like Ozempic or Wegovy, or tirzepatide, like … Read more
You may yet be able to lean out without losing out, as a new drug could save GLP-1 users from the flat fate of “Ozempic butt.” A symptom of rapid weight loss, Ozempic butt is characterized by a sudden loss of volume and muscle in key areas, leaving users looking and feeling deflated. And Americans … Read more
Ear we go again. In yet another plastic surgery trend sparked by GLP-1 drugs like Ozempic, patients who have dropped the pounds are now longing to plump up their sagging lobes — which, according to plastic surgeons, is a fast and easy way to give ears back their “youthful” appearance. “It seems so random, but … Read more
Popular glucagon-like peptide-1 (GLP-1) weight-loss drugs may help slow the spread of some cancers, according to new research to be presented at a major medical conference. Research led by Cleveland Clinic found that the medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers. The findings will be presented at the 2026 ASCO … Read more
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
It’s time to start trusting your gut — at least when it comes to staying young and living longer. Research has shown that the gut microbiomes of healthy older people — including those in their 90s over age 100 — often resemble those of people who are decades younger. But your gut microbiome isn’t just … Read more
The exploding popularity of GLP-1 receptor agonists like Ozempic and Wegovy is often hailed as a public health triumph, but one potential side effect may be flying under the radar. The risk of divorce increases as weight drops, according to historical data from bariatric surgery patients. Some experts believe that the same pattern could occur as … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. You lost the weight… now what? That’s the question Kourtney Kardashian-Barker’s women’s supplement brand was aiming to answer with its latest launch. The company just unveiled Lemme Metabolism, daily capsules … Read more
*Gulp* Much to the relief of the needle-shy, the FDA has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, from pharma giant Eli Lilly, promises to be even more convenient than its predecessor with similar, if slightly less drastic, weight-trimming results. The … Read more
Indiana Jones’ greatest fear may be obesity’s biggest enemy. Scientists at three universities have turned to nature to find a property that rivals the benefits of GLP-1 drugs without the laundry list of side effects. What they’ve discovered, in the cold blood of a creature that grows up to 33 feet long, is poised to … Read more
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop pounds, they drop out. Pharmaceutical manufacturers are reporting widespread instances of patients quitting their clinical trials prematurely once they realize they’ve been … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Magic pills promising to help overweight people slim down are nothing new. When I was a teenager on Staten Island, back when ephedra was still legal, I bought a bottle … Read more
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a heavyweight in the crowded world of weight-loss and diabetes treatments. But in a surprising twist, top-line results show … Read more
You’ve likely heard of diabetes, a chronic condition that affects how the body regulates blood sugar. But are you familiar with prediabetes? Prediabetes is a state of elevated blood sugar that falls below the threshold of Type 2 diabetes. It’s becoming increasingly common: More than 1 in 3 US adults has prediabetes, and most aren’t … Read more
Too good to be true? While blockbuster GLP-1 drugs continue to reach new heights in popularity, they’re not without potential downsides, like bizarre side effects such as “Ozempic feet.” And while they boast impressive blood sugar and weight loss results — average weight lost is nearly 10% over a year — making one mistake could … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits. Aside from the impressive results, GLP-1s seem to be increasingly … Read more
“Dry January” is getting replaced by something a lot more modern: half of Americans say taking GLP-1 medications is the next big wellness trend. The poll of 2,000 US adults found nearly a quarter (23%) currently use GLP-1s or have used them within the past five years. And when asked if they would rather ditch … Read more
About one in eight Americans have tried GLP-1 drugs like Mounjaro, Zepbound and Ozempic — and they’ve shrunken appetites so dramatically that people are spending noticeably less on groceries. But one dietitian and LillyDirect partner — a platform from Eli Lilly, which sells Mounjaro and Zepbound — tells The Post there are actually lots of … Read more
Here’s the skinny on Chipotle’s new “GLP-1 friendly” menu. This coming Tuesday, Chipotle will debut its High Protein Menu –and it proves how weight-loss drugs such as Ozempic and Wegovy are altering the way people eat. “With the rise of GLP-1s and a broader focus on macronutrients, Chipotle’s new High Protein Menu offers more ways … Read more